161 related articles for article (PubMed ID: 9108396)
1. Human platelets as a model for the binding and degradation of thrombopoietin.
Fielder PJ; Hass P; Nagel M; Stefanich E; Widmer R; Bennett GL; Keller GA; de Sauvage FJ; Eaton D
Blood; 1997 Apr; 89(8):2782-8. PubMed ID: 9108396
[TBL] [Abstract][Full Text] [Related]
2. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.
Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ
Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374
[TBL] [Abstract][Full Text] [Related]
3. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
Li J; Xia Y; Kuter DJ
Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590
[TBL] [Abstract][Full Text] [Related]
4. Human platelets display high-affinity receptors for thrombopoietin.
Broudy VC; Lin NL; Sabath DF; Papayannopoulou T; Kaushansky K
Blood; 1997 Mar; 89(6):1896-904. PubMed ID: 9058709
[TBL] [Abstract][Full Text] [Related]
5. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
Li J; Xia Y; Kuter DJ
Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
[TBL] [Abstract][Full Text] [Related]
6. Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.
Scheding S; Bergmann M; Shimosaka A; Wolff P; Driessen C; Rathke G; Jaschonek K; Brugger W; Kanz L
Transfusion; 2002 Mar; 42(3):321-7. PubMed ID: 11961237
[TBL] [Abstract][Full Text] [Related]
7. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
8. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
[TBL] [Abstract][Full Text] [Related]
9. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.
Horikawa Y; Matsumura I; Hashimoto K; Shiraga M; Kosugi S; Tadokoro S; Kato T; Miyazaki H; Tomiyama Y; Kurata Y; Matsuzawa Y; Kanakura Y
Blood; 1997 Nov; 90(10):4031-8. PubMed ID: 9354672
[TBL] [Abstract][Full Text] [Related]
10. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
Guo Y; Bian S; Luo M
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
[TBL] [Abstract][Full Text] [Related]
12. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of biological activity and inhibition of receptor binding by antibodies against human thrombopoietin.
Tahara T; Kuwaki T; Matsumoto A; Morita H; Watarai H; Inagaki Y; Ohashi H; Ogami K; Miyazaki H; Kato T
Stem Cells; 1998; 16(1):54-60. PubMed ID: 9474748
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice.
Stefanich E; Senn T; Widmer R; Fratino C; Keller GA; Fielder PJ
Blood; 1997 Jun; 89(11):4063-70. PubMed ID: 9166846
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin in vitro and in vivo.
Alexander WS; Begley CG
Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
[TBL] [Abstract][Full Text] [Related]
17. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
[TBL] [Abstract][Full Text] [Related]
18. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
Broudy VC; Lin NL
Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
20. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]